» Articles » PMID: 36508210

Target Trial Emulation: A Framework for Causal Inference From Observational Data

Overview
Journal JAMA
Specialty General Medicine
Date 2022 Dec 12
PMID 36508210
Authors
Affiliations
Soon will be listed here.
Citing Articles

Reduced risks of influenza-associated hospitalization and complications following vaccination among over 2 million older individuals: a nationwide study using target trial emulation framework.

Peng Z, Hua Y, Huang W, Wu J, Ou H BMC Med. 2025; 23(1):157.

PMID: 40082958 PMC: 11907999. DOI: 10.1186/s12916-025-03955-w.


Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study.

Onishi A, Tanaka M, Fujii T, Murata K, Murakami K, Hashimoto M Arthritis Res Ther. 2025; 27(1):52.

PMID: 40055759 PMC: 11887301. DOI: 10.1186/s13075-025-03514-x.


Disproportionality Analysis and Causal Inference in Drug Safety.

Scosyrev E, Behr S, Jain D, Ponnuru A, Michel C Pharmaceut Med. 2025; .

PMID: 40032799 DOI: 10.1007/s40290-024-00549-4.


Hepatitis B vaccination of preterm infants and risk of bronchopulmonary dysplasia: a cohort study, Australia.

Morgan H, Nold M, Kattan G, Vlasenko D, Malhotra A, Boyd J Bull World Health Organ. 2025; 103(3):187-193.

PMID: 40026670 PMC: 11865856. DOI: 10.2471/BLT.24.291683.


The EU project Real4Reg: unlocking real-world data with AI.

Peltner J, Becker C, Wicherski J, Wortberg S, Aborageh M, Costa I Health Res Policy Syst. 2025; 23(1):27.

PMID: 40016823 PMC: 11869640. DOI: 10.1186/s12961-025-01287-y.